Meanwhile, Pharmac's decision to fund the budesonide, glycopyrronium and formoterol aerosol inhaler is expected to help 5000 ...

Pharmac will also fund osimertinib for people with a type of advanced non-small cell lung cancer. About 20 percent of people with non-small cell lung cancer have a mutation in their cancer that can be ...

"We refer to our earlier communication dated December 2, 2023, intimating the receipt of Import and Market Permission in Form CT-20 from the Drugs Controller General of India for Budesonide Ph. Eur ...

Proton pump inhibitors (PPIs) were commonly used as a first-line treatment, with most patients receiving PPI therapy. Other treatment modalities, such as oral budesonide and exclusion diets either ...